Sander Slootweg's most recent trade in Replimune Group Inc was a trade of 25,200 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 1, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Replimune Group Inc | Sander Slootweg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 25,200 | 25,200 | - | - | Stock Option (right to buy) | |
Replimune Group Inc | Sander Slootweg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
Replimune Group Inc | Sander Slootweg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
Replimune Group Inc | Sander Slootweg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2020 | 16,500 | 16,500 | - | - | Stock Option (right to buy) |